Carestream Shares Path to Accelerated Delivery of AI Features at HPE Discover 2022 Conference

Carestream Health will share its path and commitment to delivering artificial-intelligence-powered features for medical imaging at the HPE Discover Edge-to-Cloud user conference June 28-30.

Carestream is the featured healthcare company at the conference, delivering a session on “Transforming Healthcare: Carestream Delivers AI with Edge-to-Cloud Platform” and participating in a panel on “Accelerating Your Transformation with the Cloud Experience Everywhere – From Customers Who Have.”

Carestream leverages HPE GreenLake’s enterprise-grade cloud service for machine learning (ML Ops platform) to accelerate development of its AI applications for medical imaging. The platform enables an accelerated workflow for research, including testing AI models on clinical data, getting faster feedback and deploying better solutions.

“Carestream is leveraging AI in our medical imaging solutions to develop new applications that help improve clinical outcomes and patient care, and accelerate workflow,” said Dharmendu Damany, Chief Technology Officer at Carestream. “HPE’s ML Ops platform helps us deliver our innovative solutions to the healthcare market more quickly.”

The HPE platform provides the massive computing power necessary to accelerate Carestream’s development of AI-powered imaging, workflow automation and analytics innovations. Case in point: Carestream had a significant reduction in the time to execute a training run for its AI-based Smart Noise Cancellation from ~60 hours to 16. Smart Noise Cancellation provides improved diagnostic quality, preservation of fine detail and better contrast-to-noise ratio for images acquired at clinically nominal exposures.*

“HPE gives us a platform to successfully manage the expanding scope and scale of our AI activities. Additionally, it frees up our imaging scientists to focus more time on creating solutions for our customers in healthcare and less energy on building the ‘plumbing’ needed for AI solution creation,” explained Mr. Damany.

Carestream’s presentation on “Transforming Healthcare: Carestream Delivers AI with Edge-to-Cloud Platform” will be delivered on Wednesday, June 29 at noon by John Kopcienski, Director, Systems Architecture and Platformed Components, and Mark Hourani, AI & Data Practice Lead at HPE. Mr. Kopcienski will join the panel discussion on “Accelerating Your Transformation with the Cloud Experience Everywhere – From Customers Who Have” on June 29 at 4:30 p.m.

*These statements were verified using Carestream detectors in a reader study performed by board certified radiologists comparing pairwise images taken at nominal dose (CsI ISO 400 speed / GOS ISO 320 speed) and reduced dose (CsI ISO 800 speed / GOS ISO 500 speed) with SNC. This study led to an FDA 510k clearance of SNC for dose reduction.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”